A 20‐year pancreatic cancer surveillance study of 347 CDKN2A PGV carriers identified 36 PDAC cases in 31 (8.9%) individuals through annual magnetic resonance imaging.57 Here, CDKN2A is linked to pancreatic neoplasm.